e-learning
resources
Virtual 2020
Pre-Congress Content
Monitoring of patients with COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Can reversibility determine clinical course in patients with COPD?
K. Dmytriiev (Vinnitsya, Ukraine), Y. Mostovoy (Vinnitsya, Ukraine), N. Slepchenko (Vinnitsya, Ukraine), N. Tsymbaliuk (Vinnitsya, Ukraine), A. Sidorov (Vinnitsya, Ukraine), D. Dmytriiev (Vinnitsya, Ukraine), M. Shostatska (Vinnitsya, Ukraine)
Source:
Virtual Congress 2020 – Monitoring of patients with COPD
Session:
Monitoring of patients with COPD
Session type:
E-poster session
Number:
1041
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Dmytriiev (Vinnitsya, Ukraine), Y. Mostovoy (Vinnitsya, Ukraine), N. Slepchenko (Vinnitsya, Ukraine), N. Tsymbaliuk (Vinnitsya, Ukraine), A. Sidorov (Vinnitsya, Ukraine), D. Dmytriiev (Vinnitsya, Ukraine), M. Shostatska (Vinnitsya, Ukraine). Can reversibility determine clinical course in patients with COPD?. 1041
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Dynapenia in COPD exacerbation: what is its relevance in clinical prognosis?
Source: International Congress 2017 – Assessing functional outcomes in respiratory physiotherapy
Year: 2017
Does the duration of symptoms pre admission influence the clinical course of the exacerbation in COPD?
Source: Eur Respir J 2004; 24: Suppl. 48, 15s
Year: 2004
Does a predominant clinical COPD phenotype predict different outcome responses to pulmonary rehabilitation?
Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care
Year: 2012
Does aging affect the outcome of comprehensive pulmonary rehabilitation in patients with COPD?
Source: Eur Respir J 2003; 22: Suppl. 45, 426s
Year: 2003
Regional differences in the treatment of patients with moderate COPD enrolled in a global clinical trial
Source: Annual Congress 2006 - Recent advances in the treatment of COPD
Year: 2006
Evaluation of adequacy of pharmacological treatment in relation to severity in patients with chronic obstructive pulmonary disease (COPD) and their clinical correlations.
Source: International Congress 2018 – Pharmacological management of COPD
Year: 2018
Can we predict who is mostly likely to re-exacerbate after a COPD exacerbation?
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008
A randomised clinical trial to assess the effect of active muscle stimulation on hospitalised patients with COPD exacerbations
Source: Annual Congress 2012 - The best posters on physical inactivity, muscle dysfunction and exercise intolerance
Year: 2012
Analysis of two-year treatment with omalizumab patients with severe asthma in real clinical practice
Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma
Year: 2019
Is blood eosinophil count a biomarker for chronic obstructive pulmonary disease in a real-world clinical setting? Predictive property and longitudinal stability in Japanese patients.
Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases
Year: 2021
Does an acute FEV1 response predict long-term improvements with bronchodilators in patients with COPD?
Source: Eur Respir J 2001; 18: Suppl. 33, 486s
Year: 2001
Do cardiac biomarkers predict long-term outcomes from exacerbations of COPD?
Source: International Congress 2017 – Highlights on clinical problems in COPD
Year: 2017
Lung function indices versus symptoms for monitoring the course of the disease in patients with COPD
Source: Annual Congress 2008 - Functionality and metabolism in rehabilitation candidates
Year: 2008
Can roflumilast improve clinical outcomes in moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016
Temporal profile and clinical utility of inflammatory markers in patients with acute exacerbation of COPD
Source: Annual Congress 2008 - Structural remodelling in COPD
Year: 2008
Need for generalized criteria in evaluating the impact of new drugs in clinical trials involving patients suffering from COPD
Source: Annual Congress 2006 - Outcomes for COPD pharmacological trials: from lung function to biomarkers
Year: 2006
Clinical and functional effectiveness of roflumilast in severe COPD patients
Source: Annual Congress 2013 –Modern approach to various clinical settings
Year: 2013
Clinical clustering of COPD patients is useful to predict future COPD exacerbations
Source: International Congress 2018 – New predictors of morbidity and mortality in COPD
Year: 2018
A global survey conducted to determine frequency of exacerbations in COPD patients
Source: Annual Congress 2013 –COPD treatment
Year: 2013
Preliminary results of relationship between appetite and clinical presentation of COPD patients in AERIS study
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept